IL134046A0 - Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide - Google Patents

Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Info

Publication number
IL134046A0
IL134046A0 IL13404698A IL13404698A IL134046A0 IL 134046 A0 IL134046 A0 IL 134046A0 IL 13404698 A IL13404698 A IL 13404698A IL 13404698 A IL13404698 A IL 13404698A IL 134046 A0 IL134046 A0 IL 134046A0
Authority
IL
Israel
Prior art keywords
diguanide
thiazolidinedione
diabetes
treatment
insulin secretagogue
Prior art date
Application number
IL13404698A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL134046A0 publication Critical patent/IL134046A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL13404698A 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide IL134046A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (1)

Publication Number Publication Date
IL134046A0 true IL134046A0 (en) 2001-04-30

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13404698A IL134046A0 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Country Status (39)

Country Link
EP (1) EP1001783B1 (enEXAMPLES)
JP (2) JP2001510159A (enEXAMPLES)
KR (1) KR100671918B1 (enEXAMPLES)
CN (1) CN1264303A (enEXAMPLES)
AP (1) AP1352A (enEXAMPLES)
AR (1) AR016349A1 (enEXAMPLES)
AT (1) ATE305790T1 (enEXAMPLES)
AU (1) AU8448898A (enEXAMPLES)
BG (1) BG64785B1 (enEXAMPLES)
BR (1) BR9810445A (enEXAMPLES)
CA (1) CA2296653C (enEXAMPLES)
CO (1) CO4940420A1 (enEXAMPLES)
CY (1) CY1105254T1 (enEXAMPLES)
DE (1) DE69831808T2 (enEXAMPLES)
DK (1) DK1001783T3 (enEXAMPLES)
DZ (1) DZ2562A1 (enEXAMPLES)
EA (1) EA003021B1 (enEXAMPLES)
ES (1) ES2251093T3 (enEXAMPLES)
GB (1) GB9715295D0 (enEXAMPLES)
HU (1) HUP0003629A3 (enEXAMPLES)
ID (1) ID24211A (enEXAMPLES)
IL (1) IL134046A0 (enEXAMPLES)
IN (1) IN189275B (enEXAMPLES)
MA (1) MA24607A1 (enEXAMPLES)
MY (1) MY155219A (enEXAMPLES)
NO (1) NO325727B1 (enEXAMPLES)
NZ (2) NZ501164A (enEXAMPLES)
OA (1) OA11279A (enEXAMPLES)
PE (1) PE99599A1 (enEXAMPLES)
PL (2) PL197844B1 (enEXAMPLES)
SA (1) SA98190468B1 (enEXAMPLES)
SI (1) SI1001783T1 (enEXAMPLES)
SK (1) SK285484B6 (enEXAMPLES)
TR (1) TR200000134T2 (enEXAMPLES)
TW (1) TW505516B (enEXAMPLES)
UA (1) UA70303C2 (enEXAMPLES)
UY (1) UY25102A1 (enEXAMPLES)
WO (1) WO1999003477A1 (enEXAMPLES)
ZA (1) ZA986363B (enEXAMPLES)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
CN1230162C (zh) * 1998-11-12 2005-12-07 史密丝克莱恩比彻姆有限公司 改进释放胰岛素致敏剂和另一抗糖尿病药的药用组合物
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP4633329B2 (ja) 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
MXPA04000180A (es) * 2001-07-10 2004-11-22 Kos Life Sciences Inc Formulacion de nucleo que comprende hidrocloruro de pioglitazona y una biguanida.
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
CA2499597C (en) * 2002-09-20 2012-01-17 Unchalee Kositprapa Multistage formulation containing a biguanide and thiazolidindione derivatives
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
TWI339586B (en) 2003-10-31 2011-04-01 Takeda Chemical Industries Ltd Solid preparation comprising pioglitazone or salt thereof,glimpiride and polyoxyethylene sorbitan fatty acid ester
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
EP0601001B1 (en) * 1991-08-26 1997-04-16 PHARMACIA & UPJOHN COMPANY Liquid food product containing 3-guanidinopropionic acid
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
DE69837089T2 (de) * 1997-06-18 2007-06-21 Smithkline Beecham P.L.C., Brentford Behandlung der diabetes mit thiazolidindion und sulfonylharnstoff

Also Published As

Publication number Publication date
NZ511608A (en) 2002-12-20
EA003021B1 (ru) 2002-12-26
CA2296653A1 (en) 1999-01-28
CN1264303A (zh) 2000-08-23
CO4940420A1 (es) 2000-07-24
SK285484B6 (sk) 2007-02-01
SA98190468B1 (ar) 2007-01-20
BG104135A (en) 2000-10-31
UA70303C2 (uk) 2004-10-15
AU8448898A (en) 1999-02-10
MA24607A1 (fr) 1999-04-01
BG64785B1 (bg) 2006-04-28
ES2251093T3 (es) 2006-04-16
ZA986363B (en) 2000-01-17
ATE305790T1 (de) 2005-10-15
UY25102A1 (es) 2000-12-29
WO1999003477A1 (en) 1999-01-28
JP2001510159A (ja) 2001-07-31
DZ2562A1 (fr) 2003-02-15
HK1028550A1 (en) 2001-02-23
DE69831808D1 (de) 2006-02-16
NZ501164A (en) 2001-06-29
CA2296653C (en) 2007-10-02
HUP0003629A3 (en) 2003-04-28
ID24211A (id) 2000-07-13
PL198017B1 (pl) 2008-05-30
HUP0003629A2 (hu) 2001-07-30
DK1001783T3 (da) 2006-02-06
TW505516B (en) 2002-10-11
DE69831808T2 (de) 2006-07-06
NO20000228D0 (no) 2000-01-17
EP1001783B1 (en) 2005-10-05
CY1105254T1 (el) 2010-03-03
AP2000001733A0 (en) 2000-03-31
KR100671918B1 (ko) 2007-01-22
TR200000134T2 (tr) 2000-09-21
AP1352A (en) 2004-12-24
JP2005213273A (ja) 2005-08-11
GB9715295D0 (en) 1997-09-24
OA11279A (en) 2003-07-31
SK592000A3 (en) 2000-09-12
MY155219A (en) 2015-09-30
IN189275B (enEXAMPLES) 2003-01-25
EP1001783A1 (en) 2000-05-24
PL338126A1 (en) 2000-09-25
NO325727B1 (no) 2008-07-07
KR20010021947A (ko) 2001-03-15
EA200000139A1 (ru) 2000-06-26
NO20000228L (no) 2000-01-17
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
BR9810445A (pt) 2000-09-05
PE99599A1 (es) 1999-12-18
AR016349A1 (es) 2001-07-04

Similar Documents

Publication Publication Date Title
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
IL134046A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
PL342517A1 (en) Methods of treating diabetes employing peptidic insulin analoques
ZA985546B (en) Treatment of insulin resistance.
HUP0003876A3 (en) Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
IL127219A0 (en) The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same
AP9901718A0 (en) Treatment of diabetes with rosiglitazone and insulin
IL133907A0 (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
IL134045A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
AP9901717A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
EP0954324A4 (en) CYCLIC PEPTID VACCINES FOR DIABETES TREATMENT AND PREVENTION
IL133138A0 (en) Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor
HK1028551A (en) Treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucosidase inhibitor
HUP0002668A3 (en) Treatment of diabetes with thiazolidinedione and metformin
HK1028198A (en) Treatment of diabetes with rosiglitazone and insulin
IL143088A0 (en) A method for the treatment of type 2 diabetes mellitus and conditions associated therewith, and a pharmaceutical composition comprising an insulin sensitiser for use in such a method
HUP0002669A3 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL94241A0 (en) Diagnosis and treatment of insulin dependent diabetes mellitus
AU8884198A (en) Diagnosis, prevention and treatment of diabetes
GB9618290D0 (en) Treatment of diabetes
IL119526A0 (en) Preparations comprising T cells for prevention or treatment of insulin dependent diabetes mellitus (IDDM)
GB9609897D0 (en) Treatment of diabetes